The National Centre for Cardiovascular Research is a Spanish research institute. The Centre was founded in 1999 and has purpose-built facilities on the campus of the Carlos III Health Institute in Madrid. The director is Valentín Fuster.

During the past decade, Centro Nacional de Investigaciones Cardiovasculares (CNIC) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)" #1 collaborator was "European Commission" with 1 trials as a collaborator and "Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)" are "Anthracycline-induced Cardiac Toxicity" (1 trials), "Non-Hodgkin Lymphoma" (1 trials) and "Persistent Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)" in a lesser frequency.

Most popular intervention types in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mapping and catheter ablation" (1 trials), "Minimally invasive surgical ablation via thoracoscopy" (1 trials), "RIPC" (1 trials), "Simulated RIPC (Sham)" (1 trials) and "Subcutaneous implantable loop recorder (ILR) implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Nacional de Investigaciones Cardiovasculares (CNIC)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Nacional de Investigaciones Cardiovasculares (CNIC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Nacional de Investigaciones Cardiovasculares (CNIC), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".